TAVIperipheral arterial diseaseNetherlands Heart RegistrationIn-hospital strokeStroke
…study using data from the Netherlands Heart Registration of all TAVI procedures performed in the Netherlands between 2013 and 2023. …
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 361–420 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Empirical antibiotic therapy4Epidural anaesthesia4Non-pharmacological interventions4Palliative radiotherapy4Preventive treatment4biologic treatment4colonoscopy4cytotoxic chemotherapy4endoscopic therapy4induction therapy4personalised medicine4ASMs4Adoptive immunotherapy4Anaesthesia4Flow diverters4Nerve blocks4antipsychotic treatment4corneal transplantation4coronary angiography4endoscopic mucosal resection4first-line chemotherapy4ketogenic diet4lumbar puncture4medical treatments4supportive measures4transfusions4vasopressor support4Cerebrospinal fluid (CSF) shunting4Chimeric Antigen Receptor T (CAR-T) cell therapy4Complete surgical excision4Continuous Positive Airway Pressure (CPAP) therapy4Coronary artery bypass grafting4FOLFIRINOX4Immunotherapy-related4Lifestyle modification4Multidisciplinary management4Pre-exposure prophylaxis4Systemic corticosteroids4Thoracic epidural analgesia4Transarterial chemoembolisation4Transcutaneous Electrical Nerve Stimulation4Vitamin A supplementation4Weight loss4adjuvant treatment4aneurysm treatment4anti-programmed cell death protein 1 therapy4antifungal therapy4antiseizure medication4chemotherapies4chronic disease management4closed reduction4device therapy4disease-modifying therapy4disease-modifying treatments4gastric decompression4gene therapies4intravenous corticosteroids4intravenous immunoglobulin therapy4multidrug therapy4neoadjuvant chemoradiotherapy4
Articles mentioning treatments
7,227 articles · page 41 of 603immunotherapybispecific T-cell engager therapyCancer Genome Atlas Research Network
…rating public and real-world multi-omics datasets to accelerate immunotherapy target discovery and validation across solid and hematological …
immunotherapyICIsNSCLCNorthwestern University
…en JBAG, Blank CU, Beets-Tan RGH. Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers. Ann Oncol. 2019; 30:998–…
immunotherapyimmunotherapies
… remain underexplored. This study evaluates trends in inpatient immunotherapy use, outcomes, and resource utilization using a large, national…
ICI rechallengemccRCCnivolumabpembrolizumabcabozantiniblenvatinibipilimumabaxitinib
…5) (figure 1).Conclusions Our results outline opportunities for ICI rechallenge, regardless of the prior immunotherapy administered. Improved o…
91.3%
PD-1 immunotherapycombination immunotherapyimmunotherapyUniversity of California IrvinemelanomanivolumabChao Family Comprehensive Cancer CenteripilimumabαPD-1
…Background PD-1 immunotherapy revolutionized cancer treatment since its approval in 2014 but …
immunotherapyHNSCCMount Sinai Institutional BiorepositoryHead and neck squamous cell carcinoma (HNSCC)Mount Sinai PPHS IRB
… largest HNSCC SCRNAseq cohort to date. Preliminary findings in immunotherapy resistant tumors compared to treatment-naïve HNSCC revealed dif…
immunotherapySABRBSCgalcisplatinmalignant cancersHNCcanine head and neck cancerPD-1 inhibitors
… therapeutics offer promise for enhancing both radiotherapy and immunotherapy, but their clinical translation is hindered by poor in vivo cle…
dual checkpoint blockadeSBRTtriple-negative breast cancerICITNBCimmune checkpoint inhibitor
… and exhausted subsets.Conclusions Compared to ICI monotherapy, dual checkpoint blockade targeting myeloid-derived inflammation can enhance antitumor im…
neoadjuvant IOimmunotherapynon-melanoma skin cancerresectable CSCCIONMSC
…s effective in improving practical K/C regarding integration of neoadjuvant IO into practice. The data also support the importance of reinforc…
combination therapysemaglutideSGLT2i
…or the significant association between hospitalization risk and combination therapy versus SGLT2i monotherapy, the corresponding E value was 1.36. …
Delayed treatment intensificationtype 2 diabetes mellitusUniversity of Gondar Comprehensive Specialised Hospitalretinopathycardioprotective medicationsdiabetic foot ulcernephropathyhypertensionheart failureneuropathy+1 more
…ng barriers to timely treatment intensification.Primary outcome Delayed treatment intensification.Results The prevalence of delayed treatment intensification was…